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Introduction
Breastfeeding accounts for up to 40% of mother-
to-child transmission (MTCT) of human immunodefi-
ciency virus (HIV) in sub-Saharan Africa. Although the
WHO/UNAIDS/UNICEF strongly advises against breast-
feeding by HIV-positive mothers, replacement feeding
in the pandemic, low-income countries is often not af-
fordable or even feasible because of the lack of clean
water or cultural stigmatization [1,2]. Interestingly, a
recent nutritional study shows that some natural com-
ponents in breast milk, such as arachidonic acid (AA)
and linolenic acid, are beneficial in reducing the risk of
MTCT of HIV [3].
Both AA and linolenic acid are bioactive long-chain
polyunsaturated fatty acids (LC-PUFAs) with a diverse
range of activities. It was suggested that LC-PUFAs could
reduce HIV transmission by inactivating the enveloped
viruses or by enhancing the viability of HIV-targeted
CD4+ T cells [3–5] (Figure 1). On the other hand, 
LC-PUFAs are well known for their protective cellular
activities against tissue lesions, e.g. during the events of
ischemia, strokes or seizures [6]. The mechanism through
which LC-PUFAs stimulate the cellular protection ma-
chinery primarily involves modulation or activation 
of two-pore-domain potassium (K2P) channels [6,7]
(Figure 2). The gene family of K2P channels was desig-
nated KCNK by the Human Genome Organization.
The extensive KCNK channel family comprises 18 gene
members, and is ubiquitously expressed in a variety of
cells, including the major HIV target, CD4+ T cells [8].
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SUMMARY
Objective: Breastfeeding by human immunodeficiency virus (HIV)-positive mothers is an unavoidable practice
in some very poor countries. It has been suggested that long-chain polyunsaturated fatty acids (LC-PUFAs) in
breast milk, such as arachidonic acid, act as natural, protective ingredients against HIV transmission. The objec-
tive of this study was to identify the protective mechanism of LC-PUFAs in cells susceptible to HIV infection 
(e.g. human CD4+ T cells, HeLa cells).
Results: LC-PUFAs are bioactive molecules capable of activating the cellular protective machinery via modula-
tion of endogenous background K+ or KCNK channels. KCNK channel expression contributes significantly 
to the stability of the cell membrane potential. During HIV-1 infection, degradation of the KCNK channel is
accelerated, and the cell membrane potential becomes pathologically depolarized. From studying functionally
distinct KCNK mutants, we found that the degree of membrane potential depolarization was directly propor-
tional to the release efficiency of HIV-1 virions. On the other hand, supplementation of KCNK channel modula-
tors such as arachidonic acid (AA) and docosahexaenoic acid (DHA) at micromolar doses could restore
hyperpolarization and stability of the cell membrane potential when endogenous KCNK channels are partially
knocked down (mimicking the depolarized state of an HIV-1-infected cell).
Conclusion: The protective mechanism of LC-PUFAs against HIV spread involves stimulation of the endogenous
KCNK channels. Our work suggests that supplementation with AA and DHA may be beneficial in reducing the risk
of HIV-1 transmission, particularly during the period of breastfeeding. [Taiwan J Obstet Gynecol 2009;48(1):65–68]
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The main function of KCNK channels is to stabilize the
cell membrane potential by conducting background K+
currents which have little time and voltage dependence
[9]. KCNK channels stabilize the cell membrane poten-
tial by drawing it toward the equilibrium potential for K+
or EK (i.e. near −90 mV in most physiologic conditions).
Thus, the expression level of endogenous K2P channels
is a key determinant of cell viability and excitability. It
has been demonstrated that during traumatic episodes
of ischemia, activation of KCNK channels by LC-PUFAs
could drive membrane potential hyperpolarization and
suppress harmful excitability or secretion [6,7,10,11].
Notably, secretion of HIV-1 virions from infected cells
could be similarly suppressed by the hyperpolarizing
activity of KCNK channels [12] (Figures 2 and 3).
We previously found that the host KCNK3 channel
is capable of restricting the release of HIV-1 virions from
infected cells. The KCNK3 channel limits viral spread by
counteracting the activity of an HIV-1-encoded protein
named Vpu [12], whose main function is to enhance
the efficiency of viral particle release by up to 100-fold.
Because Vpu bears a channel-like structure, this small
viral protein has the tendency to self-oligomerize [13] or
to promiscuously oligomerize with homologous host
channel subunits like KCNK3 [12]. Using a number of
protein and functional studies, we identified the protein–
protein interaction between host KCNK3 and HIV-1
Vpu in heterologous expression systems (i.e. HeLa and
HEK-293 cells), as well as in HIV-1-infected human
specimens. The functional consequences of their protein–
protein interaction are mutually destructive: Vpu accel-
erates degradation of the host KCNK3 channel to abolish
the background K+ conductance in HIV-1-infected cells,
while endogenous KCNK3 expression restrains the
activity of HIV-1 Vpu and viral release to some extent
[12]. Further studies using functionally distinct KCNK3
mutants revealed that the efficiency of HIV-1 release
was inversely correlated with the degree of membrane
potential hyperpolarization sustained by KCNK channel
expression (Figure 3). In other words, the expression of
background K+ channels, if not wiped out by Vpu,
should be able to halt or decelerate the release of HIV-1
virions from infected host cells.
Once a CD4+ T cell is infected with HIV, its membrane
potential and other vital homeostatic functions are dis-
rupted for the purpose of viral spread. An infected cell
gradually loses its hyperpolarizing membrane potential
until cell death. However, if the expression of background
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↑PUFA in breast milk
↓MTCT of HIV by
breastfeeding
PUFA:
• Inactivates HIV
• Supports T cell development
• Upregulates KCNK channels
Figure 1. Proposed mechanisms of breast milk long-chain
polyunsaturated fatty acids (PUFAs) as a reducer of the risk
of human immunodeficiency virus (HIV) mother-to-child
transmission (MTCT).
↑KCNK
Enhance cell viability
(e.g. neuroprotective)
Hyperpolarize
membrane potential
PUFA
Suppress HIV release
Suppress secretion
Figure 2. The cell protective mechanism of long-chain
polyunsaturated fatty acids (PUFAs) via KCNK channel mod-
ulation. HIV = human immunodeficiency virus.
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Figure 3. The efficiencies of human immunodeficiency virus
(HIV)-1 release were directly proportional to the degrees of
membrane potential depolarization. Each dot represents an
averaged value for the dual effects of KCNK3 or one of its
functionally distinct mutants on membrane potentials (x-
axis) and on HIV-1 release efficiency (y-axis). Cell membrane
potentials (Em) in a Ringer-like solution were determined by
whole-cell patch-clamp recordings [12]. The inhibitory effects
of heterologously expressed KCNK3 channels on viral particle
release were compared with the single expression of HIV-1
proviral NL4-3 (set at 100%) in HeLa cells, as previously de-
scribed [12]. The linear fit between the x and the y parameters
indicates a direct relationship between membrane potential
depolarization and efficiency of HIV-1 release.
K+ or KCNK channels is maintained or even upregulated
during HIV infection, viral secretion and spread could
conceivably be suppressed by the hyperpolarizing mem-
brane potentials (Figure 3). KCNK3 and KCNK9 are
actively expressed in human T lymphocytes [8]. Since
LC-PUFAs have been suggested as natural, protective
ingredients in breast milk against MTCT of HIV [3]
and are capable of stimulating KCNK channels [6], we
hypothesized that LC-PUFA supplementation could help
sustain KCNK channel activities and cell membrane
hyperpolarization, and be developed toward reducing
the risk of HIV transmission during breastfeeding.
Results
This work aimed to test if LC-PUFAs could enforce mem-
brane potential hyperpolarization and stability in cells
susceptible to HIV infection, thereby lowering the rate
of viral particle release during HIV-1 infection. We have
previously shown that heterologous expression of the
background K+ channel KCNK3 was capable of main-
taining membrane potential stability and suppressing
viral release in HIV-1-expressed HeLa cells [12]. As
demonstrated in Figure 3, heterologous expression 
of wild-type KCNK3 suppressed ∼50% of viral release
from HIV-1-expressed HeLa cells, and maintained the
cell membrane potentials at about −50 mV. When ex-
pressing a hyperactive KCNK3 mutant, cell membrane
potentials became more hyperpolarized and the rate
of HIV-1 release was further suppressed to below 
20% (the lower left point in Figure 3). On the other
hand, when heterologously expressing a nonfunctional
KNCK3 mutant, the channel exerted neither any hy-
perpolarizing effects on the membrane potential nor
inhibitory effects on HIV-1 release (the upper right
point in Figure 3). From studying the impacts of
KCNK3 and its point mutants in cells secreting HIV-1,
we observed an inverse relation between the efficiency
of HIV-1 particle release and the stability of the cell
membrane potential maintained by these background
K+ channels (Figure 3). Based on this relationship, the
rate of HIV-1 release could conceivably be suppressed
by hyperpolarizing potentials (as in the directions of
the horizontal and the vertical arrows in Figure 3).
We thus tested if LC-PUFA supplementation could
stimulate endogenous KCNK channel expression and in-
duce membrane potential hyperpolarization in the cells
most susceptible to HIV infection. To mimic the depolari-
zed state of HIV-infected cells, endogenous KCNK3 and
KCNK9 channels (KCNK3/9) in HIV-1-susceptible cells
(i.e. human CD4+ T cells and HeLa cells) were partially
knocked down using a low dose of the specific small
interfering RNA (siRNA). We then applied AA and
docosahexaenoic acid (DHA) at doses equivalent to the
recommended dietary intake (1–3.6μM in cell culture)
and observed if these LC-PUFAs could restore the activi-
ties of endogenous KCNK channels that were partially
knocked down. The activity of endogenous KCNK chan-
nels was assessed in terms of cell membrane potential
at different concentrations of extracellular K+ ([K+]out).
Cells were labeled by polarization-sensitive fluorescent
dye di-8-ANEPPS, and their fluorescent signals detected
by flow cytometry. In the absence of KCNK knockdown
(“control siRNA” in Figure 4), cell membrane potentials
were directly correlated with extracellular K+ content.
The correlation was much diminished in the cells with
partial KCNK3/9 knockdown. KCNK3/9 knockdown
reduced the dependency of the cell membrane poten-
tial on extracellular K+ concentration, as shown by the
flattened slope of the membrane potentials with respect
to [K+]out. Most importantly, the knockdown of endo-
genous KCNK3/9 substantially depolarized the cell
membrane potential (Figure 4). On the other hand,
the reduction in membrane potential hyperpolarization
in these KCNK3/9-knockdown cells could be restored
by supplementation with LC-PUFAs, such as AA and
DHA, to a large extent (Figure 4). The LC-PUFA sup-
plementation also restored the membrane potential
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Figure 4. The arachidonic acid (AA) + docosahexaenoic acid
(DHA) supplement restored the activity of endogenous
KCNK3/9 partially knocked down in HeLa cells. The degree
of membrane potential hyperpolarization was assessed using
di-8-ANEPPS (Invitrogen, Carlsbad, CA, USA). Partial knock-
down of endogenous KCNK3 and KCNK9 depolarized cell
membrane potentials (dashed line). The AA + DHA supple-
ment, on the other hand, activated the residual KCNK channel
activities and significantly restored cell membrane hyperpolari-
zation (gray solid vs. black solid lines). A representative experi-
ment in HeLa cells is shown. siRNA = small interfering RNA.
sensitivity to [K+]out, as demonstrated by a slope com-
parable to that of the control samples (gray solid vs.
black solid lines in Figure 4). Thus, AA and DHA were
capable of stimulating endogenous KCNK channels 
in the cells most susceptible to HIV-1 infection and
restoring their membrane potential stability.
Discussion
Our findings suggest that the mechanism which LC-
PUFAs utilize to protect against MTCT of HIV involves
modulation of endogenous KCNK channels. There-
fore, supplementation with LC-PUFAs, such as AA and
DHA, could be effective in suppressing HIV spread
(Figures 3 and 4). Although this nutrient supplementa-
tion cannot eradicate HIV, it has the potential to reduce
the risk of MTCT of HIV when and where breastfeeding
by HIV-positive mothers is unavoidable. We are currently
assessing the potencies of LC-PUFAs as anti-HIV sup-
plements during breastfeeding, as well as alternative
forms of delivery (i.e. nipple paste) in regions where clean
water and clean containers are difficult to find. This ap-
proach is expected to be feasible even for the very poor
regions of the world, since most of the dietary LC-
PUFAs are low-cost and have been popular supplements
for their other benefits (e.g., enhancement of brain
development in neonates and children).
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